Latest Listings And Ipos News

Daly Resources ended FY2026 with $11.05 million in cash after its $12 million IPO, but reported a $3.63 million loss dominated by share-based remuneration. The ASX-listed explorer has no defined mineral resources or ore reserves and must now convert its exploration portfolio into results.

European Lithium’s proposed takeover by Critical Metals Corp. can now proceed to shareholder votes, but an independent expert has warned that the share scheme is not fair, even while calling it reasonable and in shareholders’ best interests absent a superior proposal. The decisive votes are scheduled for 22 October 2026.

Franklin Templeton Australia is reshaping the FRGG Active ETF, replacing its concentrated global growth strategy with Putnam’s broader core equity approach and cutting management fees by one-third. The fund is expected to adopt the ticker FTPG in October, subject to approval, but the transition may bring tax and distribution consequences for investors.

Prescient Therapeutics has extended its Share Purchase Plan by three days after shareholders reported delays receiving application documents. The revised timetable places the offer’s results announcement just ahead of a planned briefing on the company’s PTX-100 development program.

Jindalee Lithium is moving crews onto its McDermitt project in Oregon, with Phase 1 drilling of up to 100 sites scheduled to begin in late September. Its proposed US Elemental Nasdaq listing remains targeted for the fourth quarter, although the planned US$20 million to US$30 million PIPE financing is not yet binding.

JPMorgan Equity Premium Income ETF reported a sharp fall in operating profit as fair-value losses overwhelmed higher distribution income. The fund will also switch its underlying ETF from NYSE Arca to a London-listed vehicle, while keeping its stated investment objective and total management fees and costs unchanged.

PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.

Cycliq has secured firm commitments for a $1.5 million placement priced at a steep discount, giving the cycling technology company cash for inventory, AI development and other priorities. The raise also comes with a substantial package of options and further dilution subject to shareholder approval.

Trek Metals has secured a nine-month option to acquire the 154-claim Matrix Manganese Project in Arizona for a total potential cash consideration of A$200,000. The deal offers a low-cost route into a US critical-minerals opportunity, but carries a significant related-party consideration because CEO Derek Marshall owns about 66.67% of the vendor.

Hancock Prospecting has agreed to invest A$8.77 million in White Cliff Minerals for a proposed 13.5% stake, giving the junior explorer fresh capital to accelerate drilling at its Rae Copper Project in Nunavut. The placement still requires shareholder approval.

Tivan has won approval to add 50 square kilometres to its Baucau copper-gold project in Timor-Leste, securing ground over a large magnetic anomaly. The expansion comes as the company acknowledges an executive chairman’s personal X post previewed an assay announcement before ASX release and was not authorised under its disclosure policy.

Vanguard’s audited FY2026 report records positive returns across its international equity range, led by a 35.83% total return for VAE. The report also shows the broader International Shares Index Fund grew to $56.65 billion in net assets, while PwC issued an unmodified audit opinion.